An innovator in Cell and Gene Therapy with a proprietary, flexible manufacturing platform that can enable widespread access to lifesaving treatments. Manufacturing Brighter Futures in Cell and Gene Therapy.
Location: United States, New Jersey, East Greenwich Township
Total raised: $139.4M
Founded date: 2015
Founders name: Chris Mason
Founders Related Locations: United States, District of Columbia, Washington; United Kingdom, England, London; United States, Massachusetts, Cambridge; United States, Pennsylvania, Pittsburgh
Investors 3
| Date | Name | Website |
| 09.11.2020 | Octopus Ve... | octopusven... |
| - | Amadeus Ca... | amadeuscap... |
| 02.03.2021 | Delin Vent... | delinventu... |
Funding Rounds 3
| Date | Series | Amount | Investors |
| 19.01.2022 | Series B | $100M | - |
| 15.10.2020 | Series A | $30M | - |
| 09.01.2020 | Seed | $9.4M | - |
Persons 1
| Date | First Name | Last Name | Title | |||
| - | Chris | Mason | Founder &a... | linkedin.c... | - | - |
Mentions in press and media 21
| Date | Title | Description | Source |
| 07.12.2023 | Cell and Gene Therapy Manufacturing Industry is projected to... | FMI Logo USA dominated cell & gene therapy market revenues, driven by active trials & exten... | einpresswi... |
| 09.11.2023 | Cell and Gene Therapy Manufacturing Market to Achieve a Valu... | - | globenewsw... |
| 06.06.2023 | The Cell and Gene Therapy Manufacturing Market is set to Rea... | - | globenewsw... |
| 02.09.2022 | Jay Bradner’s NIBR exit sets off a succession plan at M... | Jay Bradner → In the Big Pharma world, companies like J&J and Merck have experienced a ... | endpts.com... |
| 19.01.2022 | Ori Biotech raises over $100 million in Series B funding to ... | Ori Biotech raises over $100 million in Series B funding to launch innovative cell and gene therapy ... | cambridgen... |
| 19.01.2022 | Ori Biotech raises over $100 million in Series B funding to ... | Funds will allow for a rapid transition through pre-commercialization to market launch. London, UK ... | cambridgen... |
| 18.01.2022 | Ori Biotech Raises Over USD100M in Series B Funding | Ori Biotech Ltd., a London, UK- and and New Jersey-based leader in cell and gene therapy (CGT) manuf... | finsmes.co... |
| 18.01.2022 | Ori Biotech Raises Over $100 million in Series B Funding to ... | - | novalislif... |
| 10.08.2021 | Bringing immuno-oncology cell therapies to the masses – are ... | However, as is the case with many other paradigm-shifting technologies, it has been a long and bum... | ucltf.co.u... |
| 15.10.2020 | Ori Biotech Raises $30m in Series A financing to advance inn... | October 14 2020, London, UK and Woodcliff Lake, NJ – Ori Biotech Ltd (Ori), a leading innovator in c... | cambridgen... |
Show more